Correction to: Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies

被引：0
|
作者：
Nádia de Cássia Noronha
Amanda Mizukami
Carolina Caliári-Oliveira
Juçara Gastaldi Cominal
José Lucas M. Rocha
Dimas Tadeu Covas
Kamilla Swiech
Kelen C. R. Malmegrim
机构：
[1] Ribeirão Preto Medical School,Center for Cell
[2] University of São Paulo,based Therapy, Regional Blood Center of Ribeirão Preto
[3] University of São Paulo,Graduate Program on Bioscience and Biotechnology, School of Pharmaceutical Sciences of Ribeirão Preto
[4] In Situ Cell Therapy,Graduate Program on Basic and Applied, Immunology
[5] SUPERA Innovation and Technology Park,Department of Clinical, Toxicological and Bromatological Analysis, School of Pharmaceutical Sciences of Ribeirão Preto
[6] Ribeirão Preto Medical School,undefined
[7] University of São Paulo,undefined
[8] Department of Pharmaceutical Sciences,undefined
[9] School ofPharmaceutical Sciences of Ribeirão Preto,undefined
[10] University of São Paulo,undefined
[11] University of São Paulo,undefined
来源：
Stem Cell Research & Therapy | / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The original article [1] contained an error in the presentation of the first author’s name, Nádia de Cássia Noronha. This has now been corrected.
引用
收藏
相关论文
共 50 条
  • [21] Is there a place for mesenchymal stromal cell-based therapies in the therapeutic armamentarium against COVID-19?
    Kátia Nunes da Silva
    André Luiz Nunes Gobatto
    Zaquer Suzana Munhoz Costa-Ferro
    Bruno Raphael Ribeiro Cavalcante
    Alex Cleber Improta Caria
    Luciana Souza de Aragão França
    Carolina Kymie Vasques Nonaka
    Fernanda de Macêdo Lima
    Miquéias Lopes-Pacheco
    Patricia Rieken Macêdo Rocco
    Bruno Solano de Freitas Souza
    Stem Cell Research & Therapy, 12
  • [22] Advances in human mesenchymal stromal cell-based therapies - Towards an integrated biological and engineering approach
    Wyrobnik, Tom A.
    Ducci, Andrea
    Micheletti, Martina
    STEM CELL RESEARCH, 2020, 47
  • [23] The Pros and Cons of Mesenchymal Stem Cell-Based Therapies
    Musial-Wysocka, Aleksandra
    Kot, Marta
    Majka, Marcin
    CELL TRANSPLANTATION, 2019, 28 (07) : 801 - 812
  • [24] Efficacy of stem cell-based therapies for stroke
    Chrostek, Matthew R.
    Fellows, Emily G.
    Crane, Andrew T.
    Grande, Andrew W.
    Low, Walter C.
    BRAIN RESEARCH, 2019, 1722
  • [25] AUTOMATED APPROACHES FOR PROCESS DEVELOPMENT AND MANUFACTURE OF HUMAN MESENCHYMAL STEM CELLS FOR CELL-BASED THERAPIES
    Rafiq, Q. A.
    Nienow, A.
    Hewitt, C.
    CYTOTHERAPY, 2017, 19 (05) : S85 - S86
  • [26] Risk of tumorigenicity in mesenchymal stromal cell-based therapies-Bridging scientific observations and regulatory viewpoints
    Barkholt, Lisbeth
    Flory, Egbert
    Jekerle, Veronika
    Lucas-Samuel, Sophie
    Ahnert, Peter
    Bisset, Louise
    Buescher, Dirk
    Fibbe, Willem
    Foussat, Arnaud
    Kwa, Marcel
    Lantz, Olivier
    Maciulaitis, Romaldas
    Palomaki, Tiina
    Schneider, Christian K.
    Sensebe, Lug
    Tachdjian, Gerard
    Tarte, Karin
    Tosca, Lucie
    Salmikangas, Paula
    CYTOTHERAPY, 2013, 15 (07) : 753 - 759
  • [27] Unraveling the Complexities of Mesenchymal Stromal Cell-based Therapies: One Size Doesn't Fit All
    Weiss, Daniel J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 210 (06) : 709 - 711
  • [28] Imaging approaches for the study of cell-based cardiac therapies
    Lau, Joe F.
    Anderson, Stasia A.
    Adler, Eric
    Frank, Joseph A.
    NATURE REVIEWS CARDIOLOGY, 2010, 7 (02) : 97 - 105
  • [29] Imaging approaches for the study of cell-based cardiac therapies
    Joe F. Lau
    Stasia A. Anderson
    Eric Adler
    Joseph A. Frank
    Nature Reviews Cardiology, 2010, 7 : 97 - 105
  • [30] Correction to: Cell-Based Therapies Formulations: Unintended Components
    Fouad Atouf
    The AAPS Journal, 24
12345